Last Price$64.9(1.2%)
Market Cap$82.3B
Last Earnings date
Sep'24
Q3 2024
$1.31
39.0% beat
$97.7B
0.6% beat
Next quarter EPS Estimate
$0.94
(55.7%)YoY
CVS Earnings and Expectations
Revenue
Crunching data... Almost there!
CVS EPS (Earnings Per Share)
Crunching data... Almost there!
CVS Historical Revenue & EPS and Expectations
1Y
3Y
5Y
10Y
Revenue
EPS
CVS Earnings History
| Mar'15 | Jun'15 | Sep'15 | Dec'15 | Mar'16 | Jun'16 | Sep'16 | Dec'16 | Mar'17 | Jun'17 | Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $36.3B | $37.2B | $38.6B | $41.1B | $43.2B | $43.7B | $44.6B | $46.0B | $44.5B | $45.7B | $46.2B | $48.4B | $45.7B | $46.9B | $47.5B | $54.9B | $61.6B | $63.4B | $64.8B | $66.9B | $66.8B | $65.3B | $67.1B | $69.6B | $69.1B | $72.6B | $73.8B | $76.6B | $76.8B | $80.6B | $81.2B | $83.8B | $85.3B | $88.9B | $89.8B | $93.8B | $88.4B | $91.2B | $95.4B | $97.7B |
| Revenue estimate | $34.4B | $34.4B | $34.4B | $34.4B | $42.5B | $42.5B | $42.5B | $42.5B | $41.9B | $41.9B | $41.9B | $41.9B | $43.6B | $43.6B | $43.6B | $43.6B | $60.4B | $62.6B | $63.0B | $63.9B | $64.1B | $64.0B | $66.6B | $68.7B | $68.4B | $70.2B | $70.5B | $75.7B | $75.5B | $76.4B | $76.7B | $76.4B | $80.7B | $86.4B | $88.3B | $90.6B | $89.3B | $91.4B | $92.7B | $97.1B |
| Revenue surprise | 5.6% | 8.0% | 12.3% | 19.5% | 1.7% | 2.9% | 5.0% | 8.2% | 6.4% | 9.2% | 10.3% | 15.6% | 5.0% | 7.7% | 9.0% | 26.0% | 2.1% | 1.3% | 2.8% | 4.6% | 4.2% | 2.1% | 0.6% | 1.2% | 1.1% | 3.4% | 4.6% | 1.3% | 1.7% | 5.5% | 5.8% | 9.7% | 5.7% | 2.9% | 1.7% | 3.6% | 1.0% | 0.2% | 2.9% | 0.6% |
| EPS actual | $1.08 | $1.13 | $1.11 | $1.35 | $1.04 | $0.86 | $1.44 | $1.60 | $0.92 | $1.07 | $1.26 | $3.23 | $0.98 | ($2.52) | $1.36 | ($0.38) | $1.09 | $1.49 | $1.17 | $1.34 | $1.54 | $2.27 | $0.93 | $0.74 | $1.69 | $2.11 | $1.21 | $0.99 | $1.79 | $2.31 | ($2.59) | $1.78 | $1.66 | $1.48 | $1.76 | $1.59 | $0.88 | $1.41 | $0.07 | $1.31 |
| EPS estimate | $1.02 | $1.02 | $1.02 | $1.02 | $1.14 | $1.14 | $1.14 | $1.14 | $1.03 | $1.03 | $1.03 | $1.03 | $1.34 | $1.34 | $1.34 | $1.34 | $1.50 | $1.69 | $1.77 | $1.68 | $1.62 | $1.91 | $1.33 | $1.24 | $1.73 | $2.07 | $1.79 | $1.85 | $2.17 | $2.18 | $2.00 | $1.92 | $2.10 | $2.12 | $2.13 | $1.99 | $1.70 | $1.74 | $1.44 | $0.94 |
| EPS surprise | 5.9% | 10.8% | 8.8% | 32.4% | 8.8% | 24.6% | 26.3% | 40.4% | 10.7% | 3.9% | 22.3% | 213.6% | 26.9% | 288.1% | 1.5% | 128.4% | 27.5% | 12.0% | 33.9% | 20.3% | 5.2% | 18.8% | 30.1% | 40.2% | 2.1% | 2.1% | 32.2% | 46.4% | 17.4% | 5.9% | 229.7% | 7.4% | 21.1% | 30.1% | 17.4% | 20.1% | 48.1% | 18.9% | 95.2% | 39.0% |
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
$97.7B 4.2% YoY
Cost of revenue
$84.8B 6.1% YoY
Pre-tax income
$2,126.0M (21.4%) YoY
2.2% margin
Competing with CVS Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$82.3B | $372.8B | $3.67 | 4.2% | (17.6%) | Beat by 0.6% | Beat by 39.0% | (5.0%) | 2.8% | Beats: 7 Misses: 3 | 3.5% | 61.9% | |
$436.0B | $398.3B | $15.59 | 8.1% | 1.4% | Beat by 1.7% | Miss by 14.6% | 10.0% | 23.0% | Beats: Misses: | 12.0% | 92.3% | |
$90.7B | $176.8B | $25.69 | 6.6% | (51.8%) | Beat by 1.2% | Miss by 55.5% | 0.2% | 488.9% | Beats: 8 Misses: 2 | 7.0% | 34.5% | |
$87.2B | $245.3B | $12.25 | 28.7% | 45.0% | Beat by 4.1% | Miss by 35.4% | (9.1%) | 37.2% | Beats: 9 Misses: 1 | 24.7% | 62.2% | |
$31.5B | $117.8B | $10.00 | 10.4% | 30.3% | Beat by 1.4% | Beat by 163.6% | 5.2% | (222.1%) | Beats: 8 Misses: 2 | 1.6% | 68.2% | |
$29.1B | $163.1B | $6.27 | 3.4% | 577.0% | Beat by 3.7% | Beat by 15.2% | 2.8% | 292.9% | Beats: 8 Misses: 2 | 3.8% | 14.2% | |
$17.3B | $40.6B | $20.50 | 16.0% | 19.4% | Beat by 1.7% | Miss by 23.0% | 0.2% | 48.7% | Beats: 9 Misses: 1 | 6.8% | 26.5% | |
$3,703.3M | $9,177.6M | $0.17 | 67.1% | (6.1%) | Miss by 2.8% | Beat by 5.1% | 15.5% | (207.5%) | Beats: 6 Misses: 4 | 25.5% | 583.9% | |
$3,104.9M | $2,703.6M | ($0.68) | 50.7% | (36.0%) | Beat by 3.9% | Miss by 14.9% | 22.0% | 33.4% | Beats: 4 Misses: 6 | 46.8% | (13.3%) | |
$1,871.6M | $1,370.6M | ($0.09) | (33.3%) | (70.1%) | Miss by 2.9% | Miss by 31.9% | 18.0% | 2.8% | Beats: 8 Misses: 2 | (32.1%) | (73.1%) |
FAQ
1. When was CVS Health Corporation's last earnings date?
CVS Health Corporation's last earnings date was Sep'24 (Q3 2024).
2. What is CVS Health Corporation's EPS, and was there a surprise?
CVS Health Corporation's EPS was $1.31, with a 39.0% beat.
3. What is CVS Health Corporation's revenue, and was there a surprise?
CVS Health Corporation's revenue was $97.7B, with a 0.6% beat.
4. What is CVS Health Corporation's next quarter EPS estimate?
CVS Health Corporation's next quarter EPS estimate is $0.94, with an expected (55.7%) YoY growth.